A Study of Insulin Glargine (LY2963016) in Healthy Chinese Participants
Clinical trial NCT03555305 · COMPLETED
Trial details
- NCT number
- NCT03555305
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-26
- Primary completion
- 2019-11-04
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.